1616470-04-2

Basic information

• Product Name: (2R,3S)-1-ethoxy-3-hydroxy-4-((4R,5R)-5-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-oxobutan-2-yl benzoate
• Synonyms: (2R,3S)-1-ethoxy-3-hydroxy-4-((4R,5R)-5-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-oxobutan-2-yl benzoate
• CAS NO: 1616470-04-2
• Molecular Weight: 516.588
• Mol File: 1616470-04-2.mol

Chemical Properties

• CAS DataBase Reference: (2R,3S)-1-ethoxy-3-hydroxy-4-((4R,5R)-5-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-oxobutan-2-yl benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S)-1-ethoxy-3-hydroxy-4-((4R,5R)-5-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-oxobutan-2-yl benzoate(1616470-04-2)
• EPA Substance Registry System: (2R,3S)-1-ethoxy-3-hydroxy-4-((4R,5R)-5-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-oxobutan-2-yl benzoate(1616470-04-2)

Safety Data

• Hazardous Substances Data: 1616470-04-2(Hazardous Substances Data)

Upstream product

• 1616470-00-8 C₂₁H₃₂O₈ 
• 707-07-3 orthobenzoic acid trimethyl ester 
• 98-88-4 benzoyl chloride 

Relevant articles and documents

Total syntheses and in vivo quantitation of novel neurofuran and dihomo-isofuran derived from docosahexaenoic acid and adrenic acid

Neurofurans (NeuroFs) and dihomo-isofurans (dihomo-IsoFs) are produced in vivo by non-enzymatic free-radical pathways from docosahexaenoic and adrenic acids, respectively. As these metabolites are produced in minute amounts, their analyses in biological samples remain challenging. Syntheses of neurofuran and dihomo-isofurans described are based on a pivotal strategy, thanks to an enantiomerically enriched intermediate, which allowed, for the first time, access to both families: the alkenyl and enediol. Owing to this formation, quantitation of specific NeuroF and dihomo-IsoFs in biological samples was attainable.

Synthesis, discovery, and quantitation of dihomo-isofurans: Biomarkers for in vivo adrenic acid peroxidation

The growing importance of lipidomics, and the interest of non-enzymatic metabolites of polyunsaturated fatty acids (PUFAs) prompted us to initiate the synthesis of novel dihomo-IsoF compounds. Such metabolites of adrenic acid, the main PUFA in white matte